共 41 条
- [41] A Single Dose of a Novel Anti-Human Short Half-Life Engineered CD45-Targeted Antibody-Drug Conjugate (ADC) Is Cytoreductive on Patient-Derived Tumors and Extends Survival Beyond Standards of Care in Multiple Pre-Clinical Models of Hematologic Malignancy BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S96 - S96